Search results
Managing Partner. Andrew Schiff, MD. Dr. Schiff joined Aisling in 2000 and serves as one of the Managing Partners. Prior to Aisling, Dr. Schiff practiced internal medicine for six years at the New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine.
- Steven Elms Managing Partner
Steven Elms Managing Partner - Andrew Schiff, MD | Aisling...
- A.J. Sacks Analyst
A.J. Sacks Analyst - Andrew Schiff, MD | Aisling Capital
- Sunny Reddy Principal
Prior to Aisling, he was a Vice President at Lazard...
- Carol Zikopoulos Head of Human Resources and Compliance Manager
Aisling Capital Team. Aisling Capital is led by a group of...
- Wonpyo Yun Principal
Wonpyo Yun Principal - Andrew Schiff, MD | Aisling Capital
- Aftab Kherani, MD Partner
Aftab Kherani, MD Partner - Andrew Schiff, MD | Aisling...
- News
Boston, MA – December 12, 2023 – Bicara Therapeutics, a...
- Contact
To learn more about aisling capital and our funds or to...
- About
A DIFFERENTIATED APPROACH TO HEALTHCARE. Aisling Capital is...
- Steven Elms Managing Partner
Nov 10, 2017 · Aisling Capital has invested nearly $2 billion since it was founded 17 years ago — with the size of each individual investment being between $10 million and $15 million.
People also ask
Who owns Aisling capital?
Who are the principals of Aisling capital?
Who is Dr Schiff?
Who are Andrew Schiff & Chandra Leo?
Primary Organization. Aisling Capital. Location New York, New York, United States. Regions Greater New York Area, East Coast, Northeastern US. Gender Male. Investor Type Investment Partner, Individual/Angel. LinkedIn View on LinkedIn. Andrew Schiff is the Managing Partner at Aisling Capital.
- Male
- Aisling Capital
- New York
- November 17, 2015
Jun 14, 2022 · Dr. Andrew Schiff serves as Managing Partner at Aisling Capital. He also serves as Director & Treasurer at The Schiff Foundation. He serves as a Board Member, Member of the Compensation & Member of the Research and Development at Aclaris Therapeutics, Dren Bio, and Monte Rosa Therapeutics.
Jun 14, 2022 · June 14, 2022 08:02 AM Eastern Daylight Time. FOSTER CITY, Calif.-- ( BUSINESS WIRE )--Dren Bio, Inc. (“Dren Bio” or the “Company”) today announced the completion of their $65 million Series B...
Dr. Schiff joined Aisling in 2000 and serves as one of the Managing Partners. Prior to Aisling, Dr. Schiff practiced internal medicine for six years at the New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine.